DVT pathogenesis is classically explained by Virchows Triad three interacting factors: Venous stasis (immobility, prolonged bed rest, long-haul travel, heart failure, obesity, paralysis) Endothelial injury (trauma, surgery, central venous catheters, prior DVT, vasculitis) Hypercoagulability (inherited thrombophilias Factor V Leiden mutation [D68.51], prothrombin G20210A mutation [D68.52], antiphospholipid syndrome [D68.61]
One key issue parents and physicians reported as a downside of the treatment was the physical administering of the actual injections themselves
Intramuscular Injection: Injecting directly into the muscle, sometimes near the site of an injury to potentially concentrate its healing effects locally
However, significant physiological differences between species must be considered when interpreting veterinary data for human clinical applications
The FDA also recently approved daily oral pills of semaglutide for weight loss